About Andy Fleischman
Andy Fleischman is CEO and director at Illexcor Therapeutics.
Andy Fleischman appears on fund filings for Ftv.
Andy Fleischman first appears on SEC filings in 2024.
Experience
This experience comes from Andy Fleischman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andy Fleischman in the role, so the role may have started earlier or lasted longer.
AB
AmpedRNA Biosciences Current
Co-Founder
2021 – Present
Illexcor Therapeutics, Inc. Current
Chief Executive Officer (2019 – Present)
Director
2019 – Present · Henrico, VA
Develops an oral drug for people with sickle cell disease.
CD
CLEU Diagnostics Current
Co-Founder
2018 – Present
FT
TH
Thomas Jefferson University Hospitals
Resident Physician
2017 – 2021
RI
Rothman Institute
Postdoctoral Research Fellow
2015 – 2017
Key Colleagues at Startups
The people Andy Fleischman works with at each company, as listed on that company's latest Form D.
Illexcor Therapeutics, Inc. · Form D, May 8, 2026
TL
Timothy Ladin
Chief Legal Officer
MM
Maneka Mirchandaney
Director
GM
Giovanni Mariggi
Director
TL
Ted Love
Director